2-(2,2-DIMETHYL-2H-CHROMEN-6-YL)ETHANOL


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	LYDCGGUVPCALHC-UHFFFAOYSA-N
Smiles	CC1(C)Oc2ccc(CCO)cc2C=C1
InChI	InChI=1S/C13H16O2/c1-13(2)7-5-11-9-10(6-8-14)3-4-12(11)15-13/h3-5,7,9,14H,6,8H2,1-2H3

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C13H16O2
Molecular Weight	204.26
AlogP	2.33
Hydrogen Bond Acceptor	2.0
Hydrogen Bond Donor	1.0
Number of Rotational Bond	2.0
Polar Surface Area	29.46
Molecular species	NEUTRAL
Aromatic Rings	1.0
Heavy Atoms	15.0

Assay Description	Organism	Bioactivity
Fungicidal activity against Botryotinia fuckeliana assessed as growth inhibition at 100 uM after 72 hr by microbioassay	Botryotinia fuckeliana	50.0 %
Antifungal activity against Colletotrichum fragariae by TLC bioautography	Colletotrichum fragariae	None
Phytotoxic activity against Cucumis sativus (cucumber) cotyledon disks assessed as electrolyte leakage	Cucumis sativus	None
Phytotoxic activity against Agrostis stolonifera var. Penncross at 0.1 to 1000 uM	Agrostis stolonifera	None
Phytotoxic activity against Lettuce cv. Iceberg (lettuce) at 0.1 to 1000 uM	Lactuca sativa	None
Termiticidal activity against Coptotermes formosanus (third-instar worker and soldier) assessed as mortality at 1% wt/wt at 26.6 degC, 100% RH measured after 21 days (Rvb= 1.3 +/- 2.5%)	Coptotermes formosanus	73.8 %
Termiticidal activity against Coptotermes formosanus (third-instar worker and soldier) assessed as mortality at 1% wt/wt at 26.6 degC, 100% RH measured after 18 days (Rvb= 1.3 +/- 2.5%)	Coptotermes formosanus	71.3 %
Termiticidal activity against Coptotermes formosanus (third-instar worker and soldier) assessed as mortality at 1% wt/wt at 26.6 degC, 100% RH measured after 15 days (Rvb= 1.3 +/- 2.5 to 5 +/- 4.1%)	Coptotermes formosanus	70.0 %
Termiticidal activity against Coptotermes formosanus (third-instar worker and soldier) assessed as mortality at 1% wt/wt at 26.6 degC, 100% RH measured after 11 days (Rvb= 1.3 +/- 2.5%)	Coptotermes formosanus	56.3 %
Termiticidal activity against Coptotermes formosanus (third-instar worker and soldier) assessed as mortality at 1% wt/wt at 26.6 degC, 100% RH measured after 8 days (Rvb= 1.3 +/- 2.5%)	Coptotermes formosanus	33.8 %
Termiticidal activity against Coptotermes formosanus (third-instar worker and soldier) assessed as mortality at 1% wt/wt at 26.6 degC, 100% RH measured after 4 days (Rvb= 0%)	Coptotermes formosanus	10.0 %
Termiticidal activity against Coptotermes formosanus (third-instar worker and soldier) assessed as mortality at 1% wt/wt at 26.6 degC, 100% RH measured after 1 day (Rvb= 0%)	Coptotermes formosanus	0.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2229476
PubChem	637149

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).